Is there a minimum standard for which stations to sample? Does lymph node size affect your recommendations?
If a patient clearly has N1 disease with high SUV on PET, do you routinely recommend EBUS or mediastinoscopy to evaluate for N2 disease?
How are your teams effectively evaluating and counseling patients to ensure they are prepared for potential extended adjuvant treatment approaches? Is...
NCCN recommends annual CT surveillance indefinitely after year 5, but I’m curious how many physicians continue and for how long?